Видео ютуба по тегу Sparsentan

The Dual Impact of Sparsentan on Inflammation and Proteinuria in IgA Nephropathy
The Dual Impact of Sparsentan on Inflammation and Proteinuria in IgA Nephropathy
Новые методы лечения IgA-нефропатии появятся в 2025 году!
Новые методы лечения IgA-нефропатии появятся в 2025 году!
Studio PROTECT: Irbesartan VS Sparsentan nella IgA Nephropathy
Studio PROTECT: Irbesartan VS Sparsentan nella IgA Nephropathy
Sparsentan and Progression to Kidney Failure in FSGS, with James Tumlin, MD
Sparsentan and Progression to Kidney Failure in FSGS, with James Tumlin, MD
Sparsentan in the Treatment of Patients With IgAN – Video abstract 430377
Sparsentan in the Treatment of Patients With IgAN – Video abstract 430377
SPARSENTAN In IgA Nephropathy: An Update On The Clinical Trials
SPARSENTAN In IgA Nephropathy: An Update On The Clinical Trials
IgA Nephropathy Game-Changer Drug Explained : Filspari (Sparsentan) vs ARBs | Positive Update
IgA Nephropathy Game-Changer Drug Explained : Filspari (Sparsentan) vs ARBs | Positive Update
Explaining Sparsentan’s Full FDA Approval and Other IgA Nephropathy Therapeutic Developments
Explaining Sparsentan’s Full FDA Approval and Other IgA Nephropathy Therapeutic Developments
Update on FDA Decision About Sparsentan for FSGS | NephCure Town Hall
Update on FDA Decision About Sparsentan for FSGS | NephCure Town Hall
Clinical Trial: Sparsentan for Treatment of IgA Nephropathy
Clinical Trial: Sparsentan for Treatment of IgA Nephropathy
Sparsentan Promising for Focal Segmental Glomerulosclerosis
Sparsentan Promising for Focal Segmental Glomerulosclerosis
Данные исследования DUPLEX спарсентана при фокальном сегментарном гломерулосклерозе
Данные исследования DUPLEX спарсентана при фокальном сегментарном гломерулосклерозе
Sparsentan shows nephroprotective potential for treatment primary focal segmental glomerulosclerosis
Sparsentan shows nephroprotective potential for treatment primary focal segmental glomerulosclerosis
Emerging Therapeutics: IgA Nephropathy
Emerging Therapeutics: IgA Nephropathy
FILSPARI (sparsentan) -reduce proteinuria in adults with primary immunoglobulin A nephropathy
FILSPARI (sparsentan) -reduce proteinuria in adults with primary immunoglobulin A nephropathy
Targeting Glomerular Injury with Sparsentan to Preserve Kidney Function in Patients with IgA
Targeting Glomerular Injury with Sparsentan to Preserve Kidney Function in Patients with IgA
IgA-нефропатия: 3 критически важных показателя, которые ваш врач может не отслеживать.
IgA-нефропатия: 3 критически важных показателя, которые ваш врач может не отслеживать.
IgA NEPHROPATHY TREATMENT PER Big Update. SPARSENTAN #ckd #kidneydisease #ckddiet
IgA NEPHROPATHY TREATMENT PER Big Update. SPARSENTAN #ckd #kidneydisease #ckddiet
Proteinuria Remission With Sparsentan in FSGS
Proteinuria Remission With Sparsentan in FSGS
#Sparsentan #drug #medication #uses #medical #words #terms #dictionary #meanings #definitions
#Sparsentan #drug #medication #uses #medical #words #terms #dictionary #meanings #definitions
Sparsentan versus Irbesartan en el tratamiento de la nefropatía por IgA.
Sparsentan versus Irbesartan en el tratamiento de la nefropatía por IgA.